Clinical trial

Evaluation of the Nociception Guided by NoL Index and Pharmacokinetics of Fentanyl in Pediatric Patients Under General Anesthesia for Non-cardiac Elective Surgery

Name
190416008
Description
Fentanyl is one of the most common used opioids for analgesia during general anesthesia, however there are few studies that describe the relationship between its pharmacokinetics and pharmacodynamics, especially in the pediatric population. The monitoring of the analgesia component during general anesthesia has been traditionally by changes in patient's vital signs, with new devices that measure nociceptive indexes like the Nociception level (NoL) index currently being validated for adults. There is still lacking evidence with nociceptive indexes in the pediatric population. Insufficient dose of opioids may cause sympathetic response, respiratory complications, development of persistent post-surgical pain and even prolonged hospitalization. In the other hand, and overdose of opioids may cause over sedation, postoperatory nausea and vomiting, respiratory depression, hyperalgesia and tolerance. Given the lack of evidence on the Pharmacokinetic and pharmacodynamic (PK/PD) of fentanyl in this group of patients, has led to raise the development of this observational prospective study; which is to describe a PK/PD model of fentanyl in pediatric population, through evaluation of the NoL index, in patients submitted to elective general non-cardiac surgery.
Trial arms
Trial start
2020-12-01
Estimated PCD
2022-12-31
Trial end
2023-03-31
Status
Completed
Treatment
Fentanyl
Standard dose of 2 ug/kg after tetanic stimulation.
Arms:
Tetanic stimulation
Tetanic stimulation
Standard tetanic stimulation will be used as the stimulus to evaluate response of the intraoperative pain index (NoL) at a standard fentanyl dose.
Arms:
Tetanic stimulation
Size
25
Primary endpoint
NoL index.
Since induction of anesthesia until emergence of anesthesia (one hour in average)
Change of the plasmatic levels of fentanyl
5, 15, 30, 45, 75 until 120 minutes after one dose of fentanyl.
Peak Plasma Concentration (Cmax)
5, 15, 30, 45, 75 until 120 minutes after one dose of fentanyl.
Eligibility criteria
Inclusion Criteria: * Children 3-10 years old * ASA I - II * Lower abdominal or urological surgery, requiring general anesthesia and caudal block Exclusion Criteria: * Obese patients * ASA III - IV - V * Allergy to fentanyl * Emergency surgery * Patients with sleep apnea * Surgeries anticipated to have an increased volume exchange or transfusion
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 25, 'type': 'ACTUAL'}}
Updated at
2023-11-27

1 organization

1 drug

3 indications

Indication
Pain
Indication
Anesthesia